The diagnosis of rhinoscleroma was confirmed in a 17-year-old female patient from Tehran, Iran, suffering from a roundish tumour of the nose. Prior treatment with streptomycin and tetracycline had been unsuccessful. A three-month course of high-dose oral ciprofloxacin (750 mg b.i.d.) led to prompt cessation of the growth of the granuloma which was removed later by plastic surgery. Although serology alone appeared to have little value for the specific diagnosis of rhinoscleroma, a significant increase of IgG antibodies during treatment with ciprofloxacin confirmed infection by Klebsiella rhinoscleromatis in this case.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/BF01728925 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Article Synopsis
- Rhinoscleroma is a chronic disease typically affecting the nose and nasopharynx, but in this case report, it presented with tracheal lesions as the first sign in an 88-year-old male.
- The patient experienced longstanding dysphonia, and examinations revealed tracheal and sinus abnormalities, with biopsy confirming the presence of rhinoscleroma.
- There is a lack of extensive literature on rhinoscleroma, especially in nonendemic regions, highlighting the need for thorough evaluation of unusual airway lesions to include rare conditions in the diagnosis.
Rhinoscleroma in a 9-year old boy: Rare case report.
Glob Pediatr Health
November 2023
Specialty Hospital of Rabat, Rabat, Morocco.
Article Synopsis
- - Rhinoscleroma is a rare but benign disease primarily affecting the respiratory tract in children, caused by the bacterium Klebsiella rhinoscleromatis, often leading to symptoms like nasal obstruction.
- - A 9-year-old patient with persistent nasal obstruction was diagnosed through a biopsy after initial treatments failed and imaging ruled out tumors, confirming rhinoscleroma via histology.
- - The child received an 8-week course of antibiotic therapy and corticosteroids, resulting in significant improvement, with ongoing follow-ups planned to monitor for potential recurrence.
[Unusual orbital involvement in chronic rhinoscleroma: Case report and review of the literature].
J Fr Ophtalmol
November 2023
Service d'ophtalmologie A, hôpital des spécialités, CHU Ibn Sina, université Mohammed V, avenue Abderrahim Bouabid, 10100 Rabat, Maroc.
Top 10 Clear Cell Head and Neck Lesions to Contemplate.
Head Neck Pathol
March 2023
All India Institute of Medical Sciences, Department of Pathology, Ansari Nagar, New Delhi, India.
Article Synopsis
- The presence of optically clear cytoplasm can occur in various lesions in the head and neck, posing diagnostic challenges due to shared characteristics between neoplastic and non-neoplastic conditions.
- The review highlights the top ten clear cell lesions, detailing their unique histological, immunohistochemical, and molecular features to aid in accurate classification.
- Key lesions discussed include clear cell carcinoma, mucoepidermoid carcinoma, and several others, emphasizing the complexity faced by pathologists in distinguishing among these conditions due to overlapping features.
A Case of Complicated Pneumonia Caused by Klebsiella ozaenae.
Cureus
March 2022
Communiy Care, Unnan City Hospital, Unnan, JPN.
Article Synopsis
- A case report discusses an 87-year-old man who developed pneumonia caused by a specific pathogen, known for causing chronic respiratory infections and some lethal infections.
- Upon hospitalization, the patient presented with fever and crackles in the lung, and imaging revealed infiltrative shadows indicative of pneumonia; blood cultures confirmed the causative pathogen.
- Initial treatment with ceftriaxone was ineffective, leading to a switch to ampicillin/sulbactam, after which the patient showed some progress and was discharged, highlighting the seriousness of infections from this pathogen and the importance of assessing immune function.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!